Hierarchical Neyman-Pearson Classification for Prioritizing Severe Disease Categories in COVID-19 Patient Data
Lijia Wang, Y. X. Rachel Wang, Jingyi Jessica Li, Xin Tong

TL;DR
This paper introduces a hierarchical Neyman-Pearson classification framework designed to prioritize severe disease categories in COVID-19 patient data, effectively controlling misclassification errors in multi-class severity prediction.
Contribution
It develops a novel hierarchical NP algorithm that adapts to existing classifiers and ensures high-probability control of critical errors in multi-class settings.
Findings
Effective control of under-classification errors in COVID-19 severity prediction.
Demonstrated applicability across various featurization methods and datasets.
Applicable to general multi-class classification with priority ordering.
Abstract
COVID-19 has a spectrum of disease severity, ranging from asymptomatic to requiring hospitalization. Understanding the mechanisms driving disease severity is crucial for developing effective treatments and reducing mortality rates. One way to gain such understanding is using a multi-class classification framework, in which patients' biological features are used to predict patients' severity classes. In this severity classification problem, it is beneficial to prioritize the identification of more severe classes and control the "under-classification" errors, in which patients are misclassified into less severe categories. The Neyman-Pearson (NP) classification paradigm has been developed to prioritize the designated type of error. However, current NP procedures are either for binary classification or do not provide high probability controls on the prioritized errors in multi-class…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSingle-cell and spatial transcriptomics · COVID-19 diagnosis using AI · COVID-19 Clinical Research Studies
